Regeneron Pharmaceuticals Stock Price - REGN

497.00
3.68 (0.75%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 493.32 486.33 503.2623 495.56 493.32 00:00:03
Bid Price Ask Price Spread Spread % News
480.00 499.90 19.90 3.98% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
19,034 1,169,783 $ 494.82 $ 578,837,265 1,810,523 271.37 - 518.00
Last Trade Time Type Quantity Stock Price Currency
19:27:07 25 $ 497.00 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 54.27B 110.02M $ 2.44B 18.45 27.00 108.21M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regeneron Pharmaceuticals News

Date Time Source News Article
4/03/202016:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
4/03/202016:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
4/03/202016:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
4/03/202016:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
4/03/202009:29Dow Jones NewsSanofi CEO: 'The One-Meeting Trip Will Disappear'
4/03/202007:29Dow Jones NewsRecession Blue-Chips' Led the Way in Another Turbulent Week..
4/03/202000:59PR Newswire (US)Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic..

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week463.09503.2623449.52490.211,422,83330.236.53%
1 Month466.94518.00418.01467.651,682,14626.385.65%
3 Months380.01518.00328.125435.901,334,059113.3129.82%
6 Months281.66518.00278.00398.731,008,836211.6675.15%
1 Year408.00518.00271.37362.15889,88085.3220.91%
3 Years383.94543.5518271.37380.72829,371109.3828.49%
5 Years434.26605.9299271.37400.99814,70959.0613.6%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.
Your Recent History
NASDAQ
REGN
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200405 07:27:48